Inventor · disambiguated record
Ensar Halilovic
Also filed as: HALILOVIC ENSAR
3 granted patents·17 pending applications·1 citations·filing 2014–2023
51Inventor score
Top patents by PatentIndex Score
20 records- 0172US10220038B2Pharmaceutical combinationsNOVARTIS AG·Filed 2018·Granted Mar 5, 2019·1 cites·9 claims
- 0270US2023398115A1Mdm2 inhibitors and combinations thereofNOVARTIS AG·Filed 2023·Application pending·0 cites
- 0361US2021260059A1Mdm2 inhibitors and combinations thereofNOVARTIS AG·Filed 2021·Application pending·0 cites
- 0460US2021386763A1Pharmaceutical combinationsNOVARTIS AG·Filed 2019·Application pending·0 cites
- 0560US2022281970A1Pharmaceutical CombinationsNOVARTIS AG·Filed 2019·Application pending·0 cites
- 0658US2020246331A1Pharmaceutical combinations and their useNOVARTIS AG·Filed 2019·Application pending·0 cites
- 0758US2019160069A1Pharmaceutical combinationsNOVARTIS AG·Filed 2019·Application pending·0 cites
- 0855US2016331751A1Pharmaceutical compositionsFERRETTI STEPHANE·Filed 2014·Application pending·0 cites
- 0954US2018015092A1Pharmaceutical combinationsNOVARTIS AG·Filed 2017·Application pending·0 cites
- 1054US2019060309A1Mdm2 inhibitors and combinations thereofNOVARTIS AG·Filed 2016·Application pending·0 cites
- 1152US2016339023A1Pharmaceutical CombinationsLI FANG·Filed 2014·Application pending·0 cites
- 1252US2017143723A1Pharmaceutical combinationsNOVARTIS AG·Filed 2017·Application pending·0 cites
- 1350US2019134033A1Pharmaceutical combinationsNOVARTIS AG·Filed 2018·Application pending·0 cites
- 1448US2018243293A1Pharmaceutical combinations and their useNOVARTIS AG·Filed 2016·Application pending·0 cites
- 1548US2018185365A1Pharmaceutical CombinationsNOVARTIS AG·Filed 2018·Application pending·0 cites
- 1647US11406627B2Combinations of MDM2 inhibitors with inhibitors of ERK for treating cancersNOVARTIS AG·Filed 2018·Granted Aug 9, 2022·0 cites·17 claims
- 1745US2022016118A1Combination of a mcl-1 inhibitor and midostaurin, uses and pharmaceutical compositions thereofSERVIER LAB·Filed 2019·Application pending·0 cites
- 1843US2021363254A1Pharmaceutical combinationsNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1935US10765680B2Combination of a MCL-1 inhibitor and a taxane compound, uses and pharmaceutical compositions thereofSERVIER LAB·Filed 2018·Granted Sep 8, 2020·0 cites·16 claims
- 2030US2019240225A1Combination of a bcl-2 inhibitor and a mcl-1 inhibitor, uses and pharmaceutical compositions thereofSERVIER LAB·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ensar Halilovic files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →